These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6087780)

  • 1. Macrophages bind directly to Semliki Forest virus-infected cells and mediate antibody-dependent cell-mediated cytotoxicity.
    Macfarlan RI; White DO
    Aust J Exp Biol Med Sci; 1984 Apr; 62 ( Pt 2)():193-7. PubMed ID: 6087780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus.
    Boere WA; Benaissa-Trouw BJ; Harmsen T; Erich T; Kraaijeveld CA; Snippe H
    Immunology; 1986 Aug; 58(4):553-9. PubMed ID: 3015781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus.
    Boere WA; Benaissa-Trouw BJ; Harmsen T; Erich T; Kraaijeveld CA; Snippe H
    J Virol; 1985 May; 54(2):546-51. PubMed ID: 2985817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspects of monoclonal antibody-mediated protection of mice against infection with virulent Semliki Forest virus.
    Boere WA; Kraaijeveld CA; Snippe H
    Antiviral Res; 1985; Suppl 1():149-53. PubMed ID: 2417548
    [No Abstract]   [Full Text] [Related]  

  • 5. Gamma interferon production and cytotoxicity of spleen cells from mice infected with Semliki Forest virus.
    Blackman MJ; Morris AG
    J Gen Virol; 1984 May; 65 ( Pt 5)():955-61. PubMed ID: 6327889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A protective monoclonal anti-idiotypic vaccine to lethal Semliki Forest virus infection in BALB/c mice.
    Oosterlaken TA; Harmsen M; Jhagjhoor-Singh SS; Ekstijn GL; Kraaijeveld CA; Snippe H
    J Virol; 1991 Jan; 65(1):98-102. PubMed ID: 1845911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of a virus membrane protein into the lipid bilayer of target cells as a prerequisite for immune cytolysis. Specific cytolysis after virosome-target cell fusion.
    Morein B; Barz D; Koszinowski U; Schirrmacher V
    J Exp Med; 1979 Dec; 150(6):1383-98. PubMed ID: 512589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of interferon-gamma in T-cell responses to Semliki Forest virus-infected murine brain cells.
    Tomkins PT; Ward GA; Morris AG
    Immunology; 1988 Mar; 63(3):355-62. PubMed ID: 2832313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cytotoxic cells in peritoneal cavity of virus-infected mice: antibody-dependent macrophages and nonspecific killer cells.
    Macfarlan RI; Burns WH; White DO
    J Immunol; 1977 Nov; 119(5):1569-74. PubMed ID: 915270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.
    Zhou X; Berglund P; Zhao H; Liljeström P; Jondal M
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):3009-13. PubMed ID: 7708765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semliki Forest virus-induced, immune-mediated demyelination: adoptive transfer studies and viral persistence in nude mice.
    Fazakerley JK; Webb HE
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():377-85. PubMed ID: 3029281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to spike protein vaccines prepared from Semliki Forest virus.
    Balcarova J; Helenius A; Simons K
    J Gen Virol; 1981 Mar; 53(Pt 1):85-92. PubMed ID: 6268742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplication of virulent and demyelinating Semliki Forest virus in the mouse central nervous system: consequences in BALB/c and SJL mice.
    Smyth JM; Sheahan BJ; Atkins GJ
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2575-83. PubMed ID: 2174955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of host and virus which influence defective interfering virus mediated-protection of mice against Semliki Forest virus lethal encephalitis. Brief report.
    Barrett AD; Dimmock NJ
    Arch Virol; 1984; 81(1-2):185-8. PubMed ID: 6331348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semliki Forest virus induced, immune mediated demyelination: the effect of irradiation.
    Fazakerley JK; Webb HE
    Br J Exp Pathol; 1987 Feb; 68(1):101-13. PubMed ID: 3028463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of linear epitopes on Semliki Forest virus E2 membrane protein and their effectiveness as a synthetic peptide vaccine.
    Snijders A; Benaissa-Trouw BJ; Oosterlaken TA; Puijk WC; Posthumus WP; Meloen RH; Boere WA; Oosting JD; Kraaijeveld CA; Snippe H
    J Gen Virol; 1991 Mar; 72 ( Pt 3)():557-65. PubMed ID: 1706409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of a systemic Semliki Forest virus infection in mice by defective interfering virus.
    Barrett AD; Dimmock NJ
    J Gen Virol; 1984 Oct; 65 ( Pt 10)():1827-31. PubMed ID: 6092526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking by anti-idiotypic antibodies of monoclonal antibody-mediated protection against lethal Semliki Forest virus in mice.
    Oosterlaken TA; Harmsen M; Kraaijeveld CA; Snippe H
    Scand J Immunol; 1990 Feb; 31(2):159-65. PubMed ID: 2155475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired interleukin 1 and interleukin 2 production following in vitro abortive infection of murine spleen mononuclear cells by Semliki Forest virus.
    Wu LX; Ilonen J; Mäkelä MJ; Salonen R; Marusyk R; Salmi AA
    Cell Immunol; 1988 Oct; 116(1):112-22. PubMed ID: 2844418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A delayed-type hypersensitivity-inducing T-cell epitope of Semliki Forest virus mediates effective T-helper activity for antibody production.
    Snijders A; Benaissa-Trouw BJ; Visser-Vernooy HJ; Fernandez I; Snippe H; Kraaijeveld CA
    Immunology; 1992 Nov; 77(3):322-9. PubMed ID: 1282493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.